Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuropeptide Y receptor type 5 (NPY5R) is a G protein-coupled receptor (GPCR) that binds neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide. It plays a role in appetite regulation, energy homeostasis, modulation of neuronal activity, cell growth signaling, and synaptic transmission. It has been implicated in epilepsy and certain cancers such as neuroblastoma, breast cancer and liver cancer.
Activation of presynaptic Y5 receptors induces a sustained increase in spontaneous GABA release from inhibitory neurons. Activation inhibits adenylate cyclase activity leading to decreased cAMP levels. Activation can also trigger ERK signaling pathways promoting cell proliferation.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide Y Receptor Type 5 (NPY5R).